Summary
Machine-generated summaryThe Kaufmännische Krankenkasse (KKH), a German statutory health insurance fund, is concluding non-exclusive rebate agreements under § 130a paragraph 8 SGB V for a specified active substance (ATC code given in the lot details, possibly limited to certain dosage forms). The procedure is an open house model with uniform contract conditions and a uniform access procedure, so every qualified pharmaceutical company or consortium that submits fully completed and signed participation documents will receive a contract. Exclusivity is excluded and joining is possible at any time on equal terms. Interested companies should request the participation documents and contract from rabattvertraege@kkh.de.
Description
Can I bid?
- Open procedure: any interested supplier may submit a bid. Above the EU threshold: open to companies from any EU country.
- The notice is written in German.
- Certificates from another EU country? Check the equivalents on eCertis
Official source
Source: TED - Tenders Electronic Daily (Publications Office of the EU)
Always verify details on the official notice.
Report an error in this notice
Last verified against TED - Tenders Electronic Daily (Publications Office of the EU) 1 month ago
More from this buyer
Full buyer profile41 open tenders right now
- Medicines - Conclusion of non-exclusive rebate agreements under § 130a para. 8 SGB V for the stated active substances via an Open House procedure 91 days left
- Medicines - Conclusion of non-exclusive rebate agreements under § 130a para. 8 SGB V for named active substances via an open-house procedure 91 days left
- Pharmaceuticals - Conclusion of non-exclusive discount agreements under § 130a(8) SGB V for the listed active substances via an open-house procedure 91 days left
This buyer has no award history in this sector yet. Usual winners, Medical equipment & pharmaceuticals - Germany
| Company | Wins | Total awarded | Last win |
|---|---|---|---|
| Siemens Healthineers AG | 43 | €20.0M | Sep 2026 |
| Philips GmbH | 21 | €7.2M | Sep 2026 |
| GlaxoSmithKline GmbH & Co. KG | 15 | n/a | Aug 2026 |
| ASTRAZENECA GMBH | 13 | n/a | Jul 2026 |
| Brainlab Sales GmbH | 11 | €4.9M | Sep 2026 |
Based on 1053 awards with a linked company profile over the last 2 years.
Change history
Every time an official source republished this notice with different content. We watch every source we index, including regional copies of the same notice.
-
Act now
- Submission deadline: Brought forward by 1 day: now December 31, 2026, 00:00
- Scope and criteria: The description was expanded. Re-read it before you bid.
Follow this tender and we email you the moment it changes. Create account
Similar tenders
Market context
- Avg. open tender · Medical equipment & pharmaceuticals
- €11,443,725
- Buyer track record on Aperlena
- 41 notices tracked · 0 awarded
Never miss a tender like this
83 new notices in Medical equipment & pharmaceuticals in Germany in the last 7 days. Get an email when new ones appear. Free.
Set up my alert